Alethia Young
CIK 1918147 · Chief Financial Officer · last filed 2026-01-06
Alethia Young is a Chief Financial Officer who has filed 18 SEC Form 4 insider transactions across 4 companies since 2022. The most recent filing, for BCYC, was dated Jan 6, 2026. Across all open-market trades the lifetime net is −$542.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.22M
4
18
-$542.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BCYC | Chief Financial Officer | 91,415 | $4.05 | $370.2K | -$77.4K | 7 | 2026-01-06 |
| PTCT | Director | 21,067 | $75.14 | $1.58M | -$465.0K | 6 | 2026-01-06 |
| PCRX | Director | 11,393 | $22.99 | $261.9K | $0 | 3 | 2025-06-13 |
| LENZ Therapeutics, Inc. (GRPH) Delisted | Chief Financial Officer | — | $22.26 | — | $0 | 2 | 2023-02-23 |
Recent Filings
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-06 | BCYC | Mixed | +42,377 | -$50.5K | EDGAR |
| 2026-01-06 | PTCT | Grant (A) | +4,000 | $0 | EDGAR |
| 2025-10-06 | BCYC | Sell (S) | −482 | -$4.1K | EDGAR |
| 2025-07-07 | BCYC | Sell (S) | −204 | -$1.4K | EDGAR |
| 2025-06-13 | PCRX | Grant (A) | +6,163 | $0 | EDGAR |
| 2025-04-04 | BCYC | Sell (S) | −215 | -$1.7K | EDGAR |
| 2025-01-07 | PTCT | Grant (A) | +4,000 | $0 | EDGAR |
| 2025-01-06 | BCYC | Mixed | +33,605 | -$19.7K | EDGAR |
| 2024-06-13 | PCRX | Grant (A) | +5,230 | $0 | EDGAR |
| 2024-02-16 | PTCT | Grant (A) | +4,000 | $0 | EDGAR |